Literature DB >> 923987

The relationship between secretory immunoglobulin A and mucus [proceedings].

J R Clamp.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 923987     DOI： 10.1042/bst0051579

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  9 in total

1.  Secretory immunoglobulin A, intestinal mucin, and mucosal permeability in nutritionally induced bacterial translocation in rats.

Authors:  G Spaeth; T Gottwald; R D Specian; M R Mainous; R D Berg; E A Deitch
Journal:  Ann Surg       Date:  1994-12       Impact factor: 12.969

2.  Transient antibody-mucin interactions produce a dynamic molecular shield against viral invasion.

Authors:  Alex Chen; Scott A McKinley; Simi Wang; Feng Shi; Peter J Mucha; M Gregory Forest; Samuel K Lai
Journal:  Biophys J       Date:  2014-05-06       Impact factor: 4.033

3.  A 70000-molecular-weight protein isolated from purified pig gastric mucus glycoprotein by reduction of disulphide bridges and its implication in the polymeric structure.

Authors:  J P Pearson; A Allen; S Parry
Journal:  Biochem J       Date:  1981-07-01       Impact factor: 3.857

4.  Immune exclusion by naturally acquired secretory IgA against pneumococcal pilus-1.

Authors:  Ulrike Binsker; John A Lees; Alexandria J Hammond; Jeffrey N Weiser
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

5.  Gut IgA abundance in adult life is a major determinant of resistance to dextran sodium sulfate-colitis and can compensate for the effects of inadequate maternal IgA received by neonates.

Authors:  Suman Gupta; Srijani Basu; Vineeta Bal; Satyajit Rath; Anna George
Journal:  Immunology       Date:  2019-07-03       Impact factor: 7.397

6.  Aggregation of Streptococcus sanguis by a neuraminidase-sensitive component of serum and crevicular fluid.

Authors:  E J Morris; B C McBride
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

7.  Intestinal mucus gel and secretory antibody are barriers to Campylobacter jejuni adherence to INT 407 cells.

Authors:  E McSweegan; D H Burr; R I Walker
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

8.  Stable nebulization and muco-trapping properties of regdanvimab/IN-006 support its development as a potent, dose-saving inhaled therapy for COVID-19.

Authors:  Morgan D McSweeney; Ian Stewart; Zach Richardson; Hyunah Kang; Yoona Park; Cheolmin Kim; Karthik Tiruthani; Whitney Wolf; Alison Schaefer; Priya Kumar; Harendra Aurora; Jeff Hutchins; Jong Moon Cho; Anthony J Hickey; Soo Young Lee; Samuel K Lai
Journal:  Bioeng Transl Med       Date:  2022-08-30

9.  IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections.

Authors:  Y-Y Wang; A Kannan; K L Nunn; M A Murphy; D B Subramani; T Moench; R Cone; S K Lai
Journal:  Mucosal Immunol       Date:  2014-02-05       Impact factor: 7.313
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.